These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry. Li G; Yang B; Li L; Zhang F; Xue C; Linhardt RJ Anal Biochem; 2014 Jun; 455():3-9. PubMed ID: 24680753 [TBL] [Abstract][Full Text] [Related]
4. Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III. Chai W; Leteux C; Westling C; Lindahl U; Feizi T Biochemistry; 2004 Jul; 43(26):8590-9. PubMed ID: 15222770 [TBL] [Abstract][Full Text] [Related]
5. Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase. Yu Y; Fu L; He P; Xia K; Varghese S; Dordick J; Wang H; Zhang F; Linhardt RJ Carbohydr Polym; 2022 Nov; 295():119825. PubMed ID: 35988993 [TBL] [Abstract][Full Text] [Related]
6. Bottom-up low molecular weight heparin analysis using liquid chromatography-Fourier transform mass spectrometry for extensive characterization. Li G; Steppich J; Wang Z; Sun Y; Xue C; Linhardt RJ; Li L Anal Chem; 2014 Jul; 86(13):6626-32. PubMed ID: 24905078 [TBL] [Abstract][Full Text] [Related]
7. Oligosaccharide mapping of low molecular weight heparins: structure and activity differences. Linhardt RJ; Loganathan D; al-Hakim A; Wang HM; Walenga JM; Hoppensteadt D; Fareed J J Med Chem; 1990 Jun; 33(6):1639-45. PubMed ID: 2160537 [TBL] [Abstract][Full Text] [Related]
8. Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry. Xu X; Li D; Chi L; Du X; Bai X; Chi L Carbohydr Res; 2015 Apr; 407():26-33. PubMed ID: 25701653 [TBL] [Abstract][Full Text] [Related]
9. Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin. Shriver Z; Sundaram M; Venkataraman G; Fareed J; Linhardt R; Biemann K; Sasisekharan R Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10365-70. PubMed ID: 10984532 [TBL] [Abstract][Full Text] [Related]
10. Preparation and structural characterization of large heparin-derived oligosaccharides. Pervin A; Gallo C; Jandik KA; Han XJ; Linhardt RJ Glycobiology; 1995 Feb; 5(1):83-95. PubMed ID: 7772871 [TBL] [Abstract][Full Text] [Related]
11. A major common trisulfated hexasaccharide core sequence, hexuronic acid(2-sulfate)-glucosamine(N-sulfate)-iduronic acid-N-acetylglucosamine-glucuronic acid-glucosamine(N-sulfate), isolated from the low sulfated irregular region of porcine intestinal heparin. Yamada S; Yamane Y; Tsuda H; Yoshida K; Sugahara K J Biol Chem; 1998 Jan; 273(4):1863-71. PubMed ID: 9442018 [TBL] [Abstract][Full Text] [Related]
12. Preparation and structure of heparin lyase-derived heparan sulfate oligosaccharides. Hileman RE; Smith AE; Toida T; Linhardt RJ Glycobiology; 1997 Mar; 7(2):231-9. PubMed ID: 9134430 [TBL] [Abstract][Full Text] [Related]
13. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site. Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846 [TBL] [Abstract][Full Text] [Related]
14. Substrate specificity of the heparin lyases from Flavobacterium heparinum. Desai UR; Wang HM; Linhardt RJ Arch Biochem Biophys; 1993 Nov; 306(2):461-8. PubMed ID: 8215450 [TBL] [Abstract][Full Text] [Related]
15. Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration. Fu L; Zhang F; Li G; Onishi A; Bhaskar U; Sun P; Linhardt RJ J Pharm Sci; 2014 May; 103(5):1375-83. PubMed ID: 24634007 [TBL] [Abstract][Full Text] [Related]
16. Influence of saccharide modifications on heparin lyase III substrate specificities. Wu J; Chopra P; Boons GJ; Zaia J Glycobiology; 2022 Mar; 32(3):208-217. PubMed ID: 33822051 [TBL] [Abstract][Full Text] [Related]